Regulation of mammalian O2 homeostasis by hypoxia- inducible factor 1

被引:1628
作者
Semenza, GL [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Pediat, Inst Med Genet, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ, Sch Med, Dept Med, Inst Med Genet, Baltimore, MD 21287 USA
关键词
cardiovascular development; ischemia; oxygen; transcription; tumor progression;
D O I
10.1146/annurev.cellbio.15.1.551
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Hypoxia-inducible factor 1 (HIF-1) is a heterodimeric basic-helix-loop-helix-PAS transcription factor consisting of HIF-1 alpha and HIF-1 beta subunits. HIF-1 alpha expression and HIF-1 transcriptional activity increase exponentially as cellular O-2 concentration is decreased. Several dozen target genes that are transactivated by HIF-1 have been identified, including those encoding erythropoietin, glucose transporters, glycolytic enzymes, and vascular endothelial growth factor. The products of these genes either increase O-2 delivery or allow metabolic adaptation to reduced O-2 availability. HIF-1 is required for cardiac and vascular development and embryonic survival. In fetal and postnatal life, HIF-1 is required for a variety of physiological responses to chronic hypoxia. HIF-1 expression is increased in tumor cells by multiple mechanisms and may mediate adaptation to hypoxia that is critical for tumor progression. HIF-1 thus appears to function as a master regulator of O-2 homeostasis that plays essential roles in cellular and systemic physiology, development, and pathophysiology.
引用
收藏
页码:551 / 578
页数:28
相关论文
共 134 条
[1]   Mersalyl is a novel inducer of vascular endothelial growth factor gene expression and hypoxia-inducible factor 1 activity [J].
Agani, F ;
Semenza, GL .
MOLECULAR PHARMACOLOGY, 1998, 54 (05) :749-754
[2]   Stabilization of wild-type p53 by hypoxia-inducible factor 1α [J].
An, WG ;
Kanekal, M ;
Simon, MC ;
Maltepe, E ;
Blagosklonny, MV ;
Neckers, LM .
NATURE, 1998, 392 (6674) :405-408
[3]   An essential role for p300/CBP in the cellular response to hypoxia [J].
Arany, Z ;
Huang, LE ;
Eckner, R ;
Bhattacharya, S ;
Jiang, C ;
Goldberg, MA ;
Bunn, HF ;
Livingston, DM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (23) :12969-12973
[4]   NEOVASCULARIZATION AND THE APPEARANCE OF MORPHOLOGICAL-CHARACTERISTICS OF THE BLOOD-BRAIN-BARRIER IN THE EMBRYONIC MOUSE CENTRAL-NERVOUS-SYSTEM [J].
BAUER, HC ;
BAUER, H ;
LAMETSCHWANDTNER, A ;
AMBERGER, A ;
RUIZ, P ;
STEINER, M .
DEVELOPMENTAL BRAIN RESEARCH, 1993, 75 (02) :269-278
[5]  
BECK I, 1993, BLOOD, V82, P704
[6]  
BECK I, 1991, J BIOL CHEM, V266, P15563
[7]  
Benzing H, 1973, Adv Exp Med Biol, V37A, P541
[8]  
BERGERON M, 1997, J CEREB BLOOD FLO S1, V17, pS505
[9]  
Bergwerff M, 1998, CIRC RES, V82, P221
[10]   Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1 [J].
Bhattacharya, S ;
Michels, CL ;
Leung, MK ;
Arany, ZP ;
Kung, AL ;
Livingston, DM .
GENES & DEVELOPMENT, 1999, 13 (01) :64-75